LIGO-069-136

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameLIGO-069-136
Drug Alias NameEleuquinPLN selectin inhibitors (LigoCyte)anti-CD62 antibody (Ligocyte)LIGO-069-136EL-246
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionLeukocyte adhesion molecule-1 inhibitorsSelectin E inhibitors
TargetsLeukocyte adhesion molecule-1Selectin E
Therapy Area/IndicationsAutoimmune DiseasesCardiovascular DiseasesPneumonia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTakeda Vaccines Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTakeda Vaccines Inc
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesCardiovascular DiseasesPneumonia

Other Information

ATC CodeN/A
Related LinksN/A